+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 80Years
All Genders
ID05870800

Phase II Study of Neoadjuvant Atezolizumab with CAPOX Chemotherapy Followed by Surgery for Resectable Non-metastatic pMMR Colon Cancer

Led by Baylor College of Medicine · Updated on 2025-05-25

28

Participants Needed

1

Research Sites

69 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a Phase II open-label trial of neoadjuvant immunochemotherapy using Atezolizumab combined with CAPOX chemotherapy, followed by surgery and possibly adjuvant chemotherapy for patients with localized resectable proficient mismatch repair pMMR adenocarcinoma of the colon. The study aims to assess the safety, feasibility, and clinical response of this combination, focusing on immune cell changes in surgically removed colon tumors. The target enrollment is 28 patients. Participants will receive 4 cycles of Atezolizumab given prior to 4 cycles of CAPOX chemotherapy over 12 weeks before standard surgical tumor removal. After surgery, patients at high risk of cancer recurrence may receive further adjuvant chemotherapy with either mFOLFOX6 or CAPOX regimens, depending on the treating oncologists decision. Blood samples will be collected throughout the study to analyze circulating tumor DNA ctDNA as an early marker of treatment effectiveness. During the study, patients will have baseline assessments including physical exams, imaging, blood, and stool collections, with continued monitoring during neoadjuvant therapy cycles. After surgery, follow-up visits occur at 2 weeks, 3 months, and 6 months to monitor health, ctDNA levels, quality of life, and treatment effects. Long-term follow-up visits occur every 6 months up to 36 months with optional research assessments. Safety, tumor response, quality of life, and survival outcomes will be measured throughout the study.

CONDITIONS

Brief Title

Phase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER

Research Team

H

Hector J Garcia-Chavez, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here